CIK 0001314102
- Non-accelerated filer
- Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262774444
- Phone
- +1 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-28 | Lurker Nancy Executive Vice Chair | Gift | +52,208 | 52,208 | ||
| 2023-12-28 | Lurker Nancy Executive Vice Chair | Gift · Stock Option (Right to Buy) | −31,164 | 62,330 | ||
| 2023-12-28 | Lurker Nancy Executive Vice Chair | Gift · Stock Option (Right to Buy) | +31,164 | 151,370 | ||
| 2023-12-28 | Lurker Nancy Executive Vice Chair | Gift · Stock Option (Right to Buy) | −10,906 | 4,674 | ||
| 2023-12-28 | Lurker Nancy Executive Vice Chair | Gift · Stock Option (Right to Buy) | +10,906 | 70,126 | ||
| 2023-12-28 | Lurker Nancy Executive Vice Chair | Gift · Stock Option (Right to Buy) | −35,000 | 130,000 | ||
| 2023-12-28 | Lurker Nancy Executive Vice Chair | Gift · Stock Option (Right to Buy) | +35,000 | 110,000 | ||
| 2023-12-28 | Lurker Nancy Executive Vice Chair | Gift · Stock Option (Right to Buy) | −31,164 | 62,330 | ||
| 2023-12-28 | Lurker Nancy Executive Vice Chair | Gift · Stock Option (Right to Buy) | +31,164 | 151,370 | ||
| 2023-12-28 | Lurker Nancy Executive Vice Chair | Gift · Stock Option (Right to Buy) | −10,906 | 4,674 | ||
| 2023-12-28 | Lurker Nancy Executive Vice Chair | Gift · Stock Option (Right to Buy) | +10,906 | 70,126 | ||
| 2023-12-28 | Lurker Nancy Executive Vice Chair | Gift · Stock Option (Right to Buy) | −35,000 | 130,000 | ||
| 2023-12-28 | Lurker Nancy Executive Vice Chair | Gift · Stock Option (Right to Buy) | +35,000 | 110,000 | ||
| 2023-12-13 | Paggiarino Dario A. Chief Medical Officer | Option exercise 10b5-1 | +1,458 | $10.13 | $15K | 27,165 |
| 2023-12-13 | Paggiarino Dario A. Chief Medical Officer | Sale 10b5-1 | −1,458 | $20.00 | $29K | 25,707 |
| 2023-12-13 | Paggiarino Dario A. Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,458 | 37,917 | ||
| 2023-12-08 | Cormorant Asset Management, LP 10% owner | Purchase | +588,235 | $17.00 | $10.0M | 6,038,235 |
| 2023-12-06 | Ocumension Therapeutics Director | Sale | −266,242 | $18.41 | $4.9M | 2,010,721 |
| 2023-12-06 | Liu Ye Director | Sale | −266,242 | $18.41 | $4.9M | 2,010,721 |
| 2023-12-05 | Ocumension Therapeutics Director | Sale | −733,758 | $19.91 | $14.6M | 2,276,963 |
Page 19 of 31 · 616 trades